Literature DB >> 31755478

Primary chondromyxoid fibroma of the orbit: An orbital mass with calcification.

Aditi Mehta Grewal1, Manpreet Singh1, Vikarn Vishwajeet2, Umang Thakur1, Ashim Das2, Pankaj Gupta1.   

Abstract

Primary orbital chondromyxoid fibroma is a rarely reported entity. A 34-year-old lady presented with painless, non-axial proptosis of the left eye of 6 months duration. Orbital imaging showed a supero-temporal mass with calcific foci and bone erosion. The mass caused globe compression resulting in choroidal folds. Anterior orbitotomy with complete mass excision was performed. The histopathology revealed a chondromyxoid fibroma. At 12-months follow-up, the patient is doing fine with no clinical recurrence. Chondromyxoid fibroma is an important differential diagnosis for bony orbital tumors.

Entities:  

Keywords:  Chondromyxoid fibroma; orbital calcification; orbitotomy; primary orbital tumorKey words:

Year:  2019        PMID: 31755478      PMCID: PMC6896519          DOI: 10.4103/ijo.IJO_1275_19

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


Primary orbital bone tumors constitute approximately 2% of all orbital masses.[1] Amongst these, the chondromyxoid fibromas (CMFs) arising from orbital bones are even rarer. The reported overall incidence of CMFs is <1% of all bone tumors, which commonly arise from the long bones of the limbs.[23] Secondary orbital involvement due to the extension of craniofacial CMFs has been infrequently reported in the literature.[45] To the best of our knowledge, the primary orbital CMFs have been reported only thrice in the English literature (summarized in Table 1).[678] In 2009, the first case of primary orbital CMF was reported by Heindel et al.[6] We describe the clinical features, radiology, histopathology, and outcomes in the first report of primary orbital CMF from our country.
Table 1

Primary orbital chondromyxoid fibromas: a review of literature

Author/yearAge/genderDurationChief complaintsEvaluationRadiologyManagementFollow-up/outcome
Heindl LM/200937y/F3 yearsLeft supero- temporal orbital mass, proptosisVisual acuity: 20/20 OU, non-axial proptosis=4 mm, choroidal folds +CT orbits: non-infiltrative mass with erosion of adjacent frontal boneTranscutaneous extra-periosteal orbitotomy with complete mass excision2 years/no recurrence (clinical)
Ditta LC/201251y/FIncidentalHistory of migraine; right orbital wall mass as an incidental finding on imagingVisual acuity: 20/20 OD & 20/30 OS; proptosis=3 mm; increased resistance to retropulsionMRI: circumscribed lobulated intraosseous mass at the zygomatico-sphenoid junctionSurgical excision of extraosseous componentRecurrence at 5 months, re-surgery with the reconstruction of lateral orbit
Mullen MG/201756y/MIncidentalHistory of chronic sinusitis; Left orbital mass detected on imaging; Previous incisional biopsy- myxofibrosarcoma and advised an exenterationVisual acuity: 20/20 OU, no proptosisCT: 3cm supero-temporal osteolytic lesion, before incisional biopsy MRI: multi-lobulated intensely enhancing expansile mass, 8 mm hypointense foci suggestive of the biopsy siteCombined neurosurgical and ophthalmologist approach for complete excision and histopathological confirmationFollow up not mentioned
Our Case34y/F5 monthsLeft non-axial proptosis of 5 months durationVisual acuity: OD 20/20 & OS 20/60, choroidal folds +,CT: superotemporal mass lesion with dense foci of calcification and effacement of orbital roofTranscutaneous anterior orbitotomy with mass excision, bony defect sealed with bone waxNo recurrence at 8 months follow up
Primary orbital chondromyxoid fibromas: a review of literature

Case Report

A 34-year-old lady had a 6-month history of painless, progressive, protrusion of the left eye. It was associated with diminution of vision for the last 3 months. On examination, the best-corrected visual acuity of the right and the left eye was 20/20 and 20/60, respectively. The left eyeball showed infero-medial displacement, 4 mm of proptosis, and limitation of elevation [Fig. 1a and b]. The fundus evaluation revealed choroidal folds at the posterior pole. A non-tender, firm-hard mass was palpable in supero-temporal quadrant of left orbit with raised retro-bulbar resistance.
Figure 1

(a) Abaxial proptosis of the left eye with infero-medial displacement, (b) Limitation of left elevation, (c) CT scan (coronal sections) showing mildly enhancing, well-circumscribed mass in supero-temporal orbit with hyperdense foci and erosion of the adjacent frontal bone, (d) The bony window of CT scan (axial, superior sections) shows the same lesion with prominent hyperdense specs of calcification

(a) Abaxial proptosis of the left eye with infero-medial displacement, (b) Limitation of left elevation, (c) CT scan (coronal sections) showing mildly enhancing, well-circumscribed mass in supero-temporal orbit with hyperdense foci and erosion of the adjacent frontal bone, (d) The bony window of CT scan (axial, superior sections) shows the same lesion with prominent hyperdense specs of calcification A computed tomography (CT) scan showed a well-defined mass in supero-temporal orbit, showing irregular hyperdense foci with surrounding frontal bone erosion [Fig. 1c and d]. The mass was not separately visualized from the lacrimal gland. After obtaining informed consent, a transcutaneous anterior orbitotomy with mass excision was performed via a sub-brow Benedict's incision. Intraoperatively, a defect measuring 10mm × 12mm was identified in the supero-temporal orbital roof which was filled with bone wax. The gross specimen measured 3 × 2.5 × 2.5 centimeters [Fig. 2a and b]. The histopathology showed the presence of a spindle/stellate type of cells in a chondroid matrix and hyaline cartilage with focal areas of ossification and few bony trabeculae [Fig. 2c and d]. The final diagnosis of chondromyxoid fibroma was established.
Figure 2

(a) Intraoperative picture showing expression of large mass with the smooth orbital surface, (b) The orbital bone side of the same mass shows irregular, bosselated surface, (c) (H and E, 40×) The section shows a lobular configuration with myxoid background and interspersed cartilage, (d) Higher magnification (H and E, 200×) shows spindle/stellate cells with few cartilaginous areas undergoing ossification

(a) Intraoperative picture showing expression of large mass with the smooth orbital surface, (b) The orbital bone side of the same mass shows irregular, bosselated surface, (c) (H and E, 40×) The section shows a lobular configuration with myxoid background and interspersed cartilage, (d) Higher magnification (H and E, 200×) shows spindle/stellate cells with few cartilaginous areas undergoing ossification Her postoperative course was uneventful with complete resolution of proptosis, significant improvement in visual acuity and restoration of elevation, although the choroidal folds persisted for 4 months. At 12-months follow-up, no clinical features of local recurrence were noted [Fig. 3a and b].
Figure 3

(a) At 12 months follow-up, the left globe appears to be in normal position with a residual sub-brow scar, (b) The left elevation has also been restored to near normal

(a) At 12 months follow-up, the left globe appears to be in normal position with a residual sub-brow scar, (b) The left elevation has also been restored to near normal

Discussion

Our case is a primary orbital CMF arising from the frontal bone with no extraorbital extension. CMFs are rare tumors presenting in 2nd to 3rd decade with a male preponderance.[23] The differential diagnosis for orbital bone tumors includes both benign (osteomas, fibrous dysplasia, chondroma, osteoblastoma and giant cell tumor) and malignant lesions (osteosarcoma, chondrosarcoma and Ewing's sarcoma).[2345] Any expansile and locally destructive lesion in the craniofacial skeleton must be evaluated and CMF should be thought of as a differential.[2345678] The CT scan features include an osteolytic lesion, well-defined lobulated margins with cortical erosion and septation (in long bones).[9] Foci of calcification may be noted in 13% cases.[23] Calcification is more common in skull-base CMFs and the younger population.[3910] On MRI, the lesion is isointense (T1W) to muscle and homogenously hyperintense (T2W) with characteristic contrast enhancement.[910] Histopathology provides the confirmative diagnosis and helps in planning further management. The histopathological differentials include both benign and malignant soft tissue, fibrous and fibro-histiocytic tumors like enchondromas, chondroblastoma, chondrosarcoma, chordoma, and myxofibrosarcoma [Table 2].[2345678] CMF is benign cartilage-forming tumors consisting of a collagenous to a myxoid matrix with the characteristic presence of stellate cells. On immunohistochemistry (IHC), they stain positive for smooth muscle antigen (SMA) and negative for keratin AE1/AE3.[23] Although Mullen et al. reported that a tailored IHC might not be very helpful for diagnosing CMF.[8]
Table 2

Differentiating clinical, radiological, histopathological and immunohistochemical features of similar orbital lesions

Chondromyxoid FibromaChondromaOsteomaMesenchymal chondrosarcoma
Clinical featuresBenign tumor 2nd to 3rd decade Male preponderanceBenign cartilaginous tumor No gender/age predilection Arise from trochlear/sphenoid boneBenign skeletal neoplasm 2nd decade Males > females Arise from paranasal sinusesRecurrent tumor±distant metastasis 2nd to 3rd decade Female preponderance
Radiology (CT scan)well-defined mass, lobulated osteolytic lesion with bony cortical erosion & foci of calcificationwell-defined mass, minimally enhancing lesion with bony scalloping and erosionwell-circumscribed mass, dense cortical sclerosis around a radiolucent niduswell defined mass, heterogeneous enhancement, bony expansion without destruction with areas of mottled and fine calcification
HistopathologyGross- smooth to bosselated surface Microscopy- cartilage-forming benign tumour with collagenous to myxoid matrix and characteristic stellate cellsGrossly- glistening smooth surface Microscopy- multi-lobulated lesion with benign spindle cells resembling hyaline cartilage, no cellular atypiaGrossly- knob like protuberances over a glistening white-pink lesion Microscopy- central nidus of loose fibrovascular tissue surrounded by irregular trabeculae of bone and osteoid matrixGrossly- lobulated surface, soft to firm consistency Microscopy- sheets/clusters of spindle- shaped mesenchymal cells; areas of cartilaginous tissue with atypia, focal calcification/cartilaginous changes
Immunohisto- chemistryS-100, SMA and SOX 9S-100 and vimentinS-100, EMA, NSE+veS-100 (cartilaginous area) Vimentin & CD99 (cellular component)

*CT: Computed tomography; SMA: Smooth muscle antigen; EMA: Epithelial membrane antigen; NSE: Neuron specific enolase

Differentiating clinical, radiological, histopathological and immunohistochemical features of similar orbital lesions *CT: Computed tomography; SMA: Smooth muscle antigen; EMA: Epithelial membrane antigen; NSE: Neuron specific enolase Enchondromas show a lobulated architecture but the presence of hyaline cartilage in these tumors is a good differentiating feature. Both CMF and chondrosarcoma stain positive for S-100 and vimentin, but the absence of fibrous stroma in orbital chondrosarcomas differentiate it from CMFs.[23] Chordomas have infiltrative margins and are composed of nests/cords of large epithelial cells with eosinophilic or vacuolated cytoplasm, which may secondarily invade the orbital bone. On IHC, the chordomas express keratin and epithelial membrane antigen.[123] In myxofibrosarcoma, a multi-nodular proliferation of stellate fibroblasts within a myxoid stroma with curvilinear blood vessels is noted. On IHC, the myxofibrosarcoma stains positive for vimentin.[123] Given the overlap of features, incisional biopsies or curettages may yield inadequate tissue leading to a possible erroneous diagnosis of malignant lesions like chondrosarcoma. This may change the further treatment course in the form of undue radiation and an unnecessary orbital exenteration. Moreover, an incomplete removal of a CMF can lead to a local recurrence. The reported recurrence rates range from 28% to 33% in the craniofacial sites.[26] Hence complete excision is recommended for both better histopathological identification and to reduce the risk of recurrence.

Conclusion

In conclusion, primary orbital chondromyxoid fibroma is an extremely rare orbital bony tumor having a few typical radiological characters, and total excision with proper histopathology should be the aim for complete management.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has given her consent for her images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  10 in total

1.  Orbital chondromyxoid fibroma.

Authors:  Ludwig M Heindl; Kerstin U Amann; Arndt Hartmann; Friedrich E Kruse; Leonard M Holbach
Journal:  Arch Ophthalmol       Date:  2009-08

Review 2.  Chondromyxoid fibroma of the anterior skull base invading the orbit in a pediatric patient: case report and review of the literature.

Authors:  Mahmoud Reza Khalatbari; Mehrdokht Hamidi; Yashar Moharamzad
Journal:  Neuropediatrics       Date:  2012-04-02       Impact factor: 1.947

3.  Chondromyxoid fibroma of the orbit.

Authors:  Lauren C Ditta; Sohail Qayyum; Thomas F O'Brien; Asim F Choudhri; Matthew W Wilson
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 Sep-Oct       Impact factor: 1.746

4.  Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases.

Authors:  C T Wu; C Y Inwards; S O'Laughlin; M G Rock; J W Beabout; K K Unni
Journal:  Hum Pathol       Date:  1998-05       Impact factor: 3.466

5.  Primary Orbital Chondromyxoid Fibroma: A Rare Case.

Authors:  Martin G Mullen; Marie Somogyi; Sean P Maxwell; Vikram Prabhu; David K Yoo
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 May/Jun       Impact factor: 1.746

6.  Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases.

Authors:  David M Meredith; Christopher D M Fletcher; Vickie Y Jo
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

7.  Chondromyxoid fibroma of the frontal bone.

Authors:  T Morimura; A Nakano; T Matsumoto; E Tani
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jul-Aug       Impact factor: 3.825

Review 8.  Primary bone tumors of the orbit.

Authors:  Dinesh Selva; Valerie A White; John X O'Connell; Jack Rootman
Journal:  Surv Ophthalmol       Date:  2004 May-Jun       Impact factor: 6.048

9.  Orbital invasion by chondromyxoid fibroma of the ethmoid sinus.

Authors:  Antonio Augusto V Cruz; Igor Marcelo Oliveira Mesquita; Aline N P Paixão Becker; Fernando Chahud
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2007 Sep-Oct       Impact factor: 1.746

10.  Imaging features of chondromyxoid fibroma: report of 15 cases and literature review.

Authors:  Sarah Cappelle; Steven Pans; Raf Sciot
Journal:  Br J Radiol       Date:  2016-05-26       Impact factor: 3.039

  10 in total
  1 in total

1.  Primary Orbital Chondromyxoid Fibroma: A Cause of Monosymptomatic Periocular Pain.

Authors:  Louise Hildestad; Steffen Heegaard; Peter Bjerre Toft
Journal:  Case Rep Ophthalmol       Date:  2021-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.